|
WO2021081253A1
|
|
Systems and methods for predicting therapeutic sensitivity
|
|
US2021118559A1
|
|
Artificial intelligence assisted precision medicine enhancements to standardized laboratory diagnostic testing
|
|
US2021115511A1
|
|
Systems and methods for next generation sequencing uniform probe design
|
|
WO2021080978A1
|
|
Calculating cell-type rna profiles for diagnosis and treatment
|
|
US2021057071A1
|
|
Unsupervised Learning And Prediction Of Lines Of Therapy From High-Dimensional Longitudinal Medications Data
|
|
WO2021034712A1
|
|
Systems and methods for detecting cellular pathway dysregulation in cancer specimens
|
|
WO2021022225A1
|
|
Methods and systems for detecting microsatellite instability of a cancer in a liquid biopsy assay
|
|
US2020395097A1
|
|
Pan-cancer model to predict the pd-l1 status of a cancer cell sample using rna expression data and other patient data
|
|
WO2020232033A1
|
|
Systems and methods for multi-label cancer classification
|
|
US2020258223A1
|
|
Determining biomarkers from histopathology slide images
|
|
WO2020198380A1
|
|
Determining biomarkers from histopathology slide images
|
|
US2020258597A1
|
|
Detection of human leukocyte antigen loss of heterozygosity
|
|
US2020255909A1
|
|
Integrated machine-learning framework to estimate homologous recombination deficiency
|
|
WO2020142566A1
|
|
Artificial intelligence segmentation of tissue images
|
|
WO2020142563A1
|
|
Transcriptome deconvolution of metastatic tissue samples
|
|
WO2020081607A1
|
|
Microsatellite instability determination system and related methods
|
|
WO2020068880A1
|
|
Methods of normalizing and correcting rna expression data
|
|
AU2019317440A1
|
|
A multi-modal approach to predicting immune infiltration based on integrated RNA expression and imaging features
|
|
WO2020010163A1
|
|
3d radiomic platform for imaging biomarker development
|
|
EP3794551A1
|
|
A generalizable and interpretable deep learning framework for predicting msi from histopathology slide images
|
